Venkataraman Balasubramanian

Array ( [id] => 9983824 [patent_doc_number] => 09029538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Uracil derivatives as AXL and c-MET kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 14/276138 [patent_app_country] => US [patent_app_date] => 2014-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60547 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14276138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670388 [patent_doc_number] => 20140234251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'PURINE NUCLEOSIDE ANALOGUES FOR TREATING FLAVIVIRIDAE INCLUDING HEPATITIS C' [patent_app_type] => utility [patent_app_number] => 14/269003 [patent_app_country] => US [patent_app_date] => 2014-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30621 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14269003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10926862 [patent_doc_number] => 20140329884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => '1,3,5-TRIAZINANE-2,4,6-TRIONE DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/267530 [patent_app_country] => US [patent_app_date] => 2014-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 56736 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14267530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9951368 [patent_doc_number] => 09000155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Cyclic triazo sodium channel blockers' [patent_app_type] => utility [patent_app_number] => 14/266398 [patent_app_country] => US [patent_app_date] => 2014-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6545 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14266398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823740 [patent_doc_number] => 08933224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Triazine derivatives' [patent_app_type] => utility [patent_app_number] => 14/265458 [patent_app_country] => US [patent_app_date] => 2014-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45495 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14265458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10506123 [patent_doc_number] => 09233988 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Silyl-protected nitrogen-containing cyclic compounds and making method' [patent_app_type] => utility [patent_app_number] => 14/264831 [patent_app_country] => US [patent_app_date] => 2014-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5272 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14264831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9671743 [patent_doc_number] => 20140235606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'CRYSTALLINE FORMS OF N-[2-[[(2,3-DIFLUOROPHENYL)METHYL]THIO]-6--4-PYRIMIDINYL]-1-AZETIDINESULFONAMIDE' [patent_app_type] => utility [patent_app_number] => 14/262863 [patent_app_country] => US [patent_app_date] => 2014-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12185 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14262863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10968413 [patent_doc_number] => 20140371447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'NOVEL ORGANOSILICON COMPOUNDS, MAKING METHODS, AND ADHESION IMPROVER' [patent_app_type] => utility [patent_app_number] => 14/258105 [patent_app_country] => US [patent_app_date] => 2014-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3847 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14258105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11911486 [patent_doc_number] => 09780310 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-03 [patent_title] => 'Heterocyclic compound for organic electroluminescent device and its application' [patent_app_type] => utility [patent_app_number] => 14/783110 [patent_app_country] => US [patent_app_date] => 2014-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 34191 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14152075 [patent_doc_number] => 10256427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-09 [patent_title] => Efficient organic electroluminescent devices [patent_app_type] => utility [patent_app_number] => 14/253811 [patent_app_country] => US [patent_app_date] => 2014-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 12545 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14253811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9643537 [patent_doc_number] => 20140221650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => '1 4,2-DIAZAPHOSPHOLIDINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/246284 [patent_app_country] => US [patent_app_date] => 2014-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3529 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14246284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10706798 [patent_doc_number] => 20160052945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'PROCESS FOR THE SILYLATION OF 2-AMINO-1,3,5-TRIAZINES' [patent_app_type] => utility [patent_app_number] => 14/782098 [patent_app_country] => US [patent_app_date] => 2014-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2179 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14782098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12408417 [patent_doc_number] => 09969738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 14/781180 [patent_app_country] => US [patent_app_date] => 2014-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11916 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9902083 [patent_doc_number] => 20150057283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'REVERSE-TURN MIMETICS AND METHOD RELATING THERETO' [patent_app_type] => utility [patent_app_number] => 14/228798 [patent_app_country] => US [patent_app_date] => 2014-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 31854 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14228798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10913116 [patent_doc_number] => 20140316135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'Process and Intermediate Compounds Useful in the Preparation of Statins, Particularly Rosuvastatin' [patent_app_type] => utility [patent_app_number] => 14/225018 [patent_app_country] => US [patent_app_date] => 2014-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3686 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14225018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10032567 [patent_doc_number] => 09073873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => '2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases' [patent_app_type] => utility [patent_app_number] => 14/223932 [patent_app_country] => US [patent_app_date] => 2014-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22419 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14223932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10700609 [patent_doc_number] => 20160046756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'PROCESS FOR PREPARING POLYISOCYANATES AND CATALYST KIT THEREFOR' [patent_app_type] => utility [patent_app_number] => 14/778870 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3894 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14778870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739808 [patent_doc_number] => 20140275528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/210666 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47025 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9832076 [patent_doc_number] => 08940893 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Heteroaromatic compounds as BTK inhibitors' [patent_app_type] => utility [patent_app_number] => 14/210517 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7827 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10614815 [patent_doc_number] => 09334246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-10 [patent_title] => 'Substituted triazines for malaria treatment and chemoprophylaxis' [patent_app_type] => utility [patent_app_number] => 14/426275 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48171 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426275 [rel_patent_id] =>[rel_patent_doc_number] =>)